Literature DB >> 2139450

Relationship between cerebrospinal fluid beta-endorphin and plasma pituitary-gonadal hormone levels in women.

C Nappi1, F Petraglia, A Gambardella, G De Masellis, C Di Carlo, A R Genazzani, U Montemagno.   

Abstract

Brain beta-endorphin (beta-EP) plays an important role in regulating the hypothalamus-pituitary-gonadal axis activity. Cerebrospinal fluid (CSF) beta-EP levels seem to reflect the central rather than pituitary secretion. With the aim to correlate the changes of plasma estradiol (E2), progesterone, luteinizing hormone (LH) and follicle-stimulating hormone with brain beta-EP, CSF levels of beta-EP were measured in 15 normally cycling and 15 postmenopausal women. CSF beta-EP levels in post-menopausal women were lower than in fertile women. A positive correlation between plasma E2 and CSF beta-EP level was found in all women. In fertile women CSF beta-EP levels were inversely correlated to plasma gonadotropin levels. These results showed that CSF beta-EP levels differ between fertile and postmenopausal women and are correlated with plasma LH and E2, suggesting a strong linkage between central beta-EP levels and pituitary-gonadal axis hormones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139450     DOI: 10.1007/bf03349526

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

Review 1.  The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides.

Authors:  M Ferin; D Van Vugt; S Wardlaw
Journal:  Recent Prog Horm Res       Date:  1984

2.  The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.

Authors:  R L Reid; M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

Review 3.  The neuroendocrinology of opioid peptides.

Authors:  A Grossman; L H Rees
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

4.  Changes in the beta-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat.

Authors:  N Barden; Y Mérand; D Rouleau; M Garon; A Dupont
Journal:  Brain Res       Date:  1981-01-12       Impact factor: 3.252

5.  Endorphins and the regulations of the human menstrual cycle.

Authors:  J Blankstein; F I Reyes; J S Winter; C Faiman
Journal:  Clin Endocrinol (Oxf)       Date:  1981-03       Impact factor: 3.478

6.  The role of endogenous opiates in LH secretion during the menstrual cycle.

Authors:  M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

7.  Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.

Authors:  J D Veldhuis; A D Rogol; M L Johnson
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

8.  Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.

Authors:  A E Panerai; F Petraglia; P Sacerdote; A R Genazzani
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

9.  Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.

Authors:  F Petraglia; G Comitini; G D'Ambrogio; A Volpe; F Facchinetti; G Alessandrini; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

10.  beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits.

Authors:  R A Houghten; R W Swann; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  2 in total

1.  Resistance training reduced luteinising hormone levels in postmenopausal women in a substudy of a randomised controlled clinical trial: A clue to how resistance training reduced vasomotor symptoms.

Authors:  Sigrid Nilsson; Moa Henriksson; Emilia Berin; David Engblom; Anna-Clara Spetz Holm; Mats Hammar
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  Acupuncture as treatment of hot flashes and the possible role of calcitonin gene-related Peptide.

Authors:  Anna-Clara E Spetz Holm; Jessica Frisk; Mats L Hammar
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-26       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.